An in vitro model for the study of human bone marrow angiogenesis: Role of hematopoietic cytokines

Laboratory Investigation

Volumn 80, Issue 4, 2000, Pages 501-511

  Pelletier, Laurent ^a,d   Regnard, Jacques ^b   Fellmann, Dominique ^b   Charbord, Pierre ^c  

^a Inst d'Etud de Transfert de Genes   (France)

^b Lab Physiologie et Pharmacologie   (France)

^c Laboratoire d'Immunologie   (France)

^d Lab d'Etud de l'Hematopoiese   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; NITRIC OXIDE; STEM CELL FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BONE MARROW CELL; ENDOTHELIUM CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0034009912     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780056     Document Type: Article

References (57)

1. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, and Steinmann L (1976). Polycythemia vera: Stem-cell and probable clonal origin of the disease. N Engl J Med 295:913-916.
2. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, and Smith LEH (1995). Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92: 10457-10461.
3. Alon T, Memo I, Itin A, Peper J, Stone J, and Keshet E (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
4. Anagnostou A, Lee ES, Kessimian N, Levinson R, and Steiner M (1990). Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978-5982.
5. Antonelli-Orlidge A, Saunders KB, Smith SR, and D'Amore PA (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548.
6. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatterman G, and Isner JM (1997). Isolation of putative progenitor endothelial cell for angiogenesis. Science 275:964-967.
7. Baatout S (1997). Endothelial differentiation using Matrigel. Anticancer Res 17:451-456.
8. Beauvais-Jouneau A and Thiery JP (1997). Multiple roles for integrins during development. Biol Cell 89:5-11.
9. Beck L and D'Amore PA (1997). Vascular development: Cellular and molecular regulation. FASEB J 11:365-373.
10. Beitz JG, Kim IS, Calabressi P, and Frackelton AR (1991). Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 88:2021-2025.
11. Benjamin LE, Golijanin D, Itin A, Pode D, and Keshet E (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159-165.
12. Benjamin LE and Keshet E (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766.
13. Brooks PC, Clark RAF, and Cheresh DA (1994). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
14. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, and Cheresh DA (1995). Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822.
15. Broudy V (1997). Stem cell factor and hematopoiesis. Blood 90:1345-1364.
16. Bulabois CE, Yerly-Motta V, Mortensen BT, Fixe P, Remy-Martin JP, Herve P, Tiberghien P, and Charbord P (1998). Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cells. J Hematother 7:225-239.
17. Bussolino F, Albini A, Camussi G, Presta M, Viglietto G, Ziche M, and Persico G (1996). Role of soluble mediators in angiogenesis. Eur J Cancer 32A:2401-2412.
18. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, Bosia A, Marchisio MC, and Montovani A (1991). In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 87:986-995.
19. Carlini RG, Reyes AA, and Rothstein M (1995). Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47:740-745.
20. Castellani P, Viale G, Dorcaratto A, Querze G, Allemanni G, Zardi L, and Siri A (1995). Specific expression of the ED-B containing fibronectin isoform by endothelial cells of growing tumor vessels. Antibody, Immunoconjugates, and Radio-pharmaceuticals 8:325-332.
21. Charbord P (1999). The microenvironmental cell population essential for the support of hematopoietic stem cells. In: Zon, L editor. Developmental biology of hematopoiesis. Oxford: Oxford University Press.
22. Charbord P, Tavian M, Humeau L, and Peault B (1996). Early ontogeny of the human marrow from long bones: An immunohistochemical study of hematopoiesis and its microenvironment. Blood 87:4109-4119.
23. Fiedler W, Graaven U, Ergun S, Verago S, Kilic N, Stockschlader M, and Hossfeld DK (1997). Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89:1870-1875.
24. Folkman J (1996). Fighting cancer by attacking its blood supply. Sci Am 275:150-154.
25. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, and Cheresh DA (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270:1500-1502.
26. Galmiche MC, Koteliansky VE, Briere J, Herve P, and Charbord P (1993). Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82: 66-76.
27. Gooch KJ, Dangler CA, and Frangos JA (1997). Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation. J Cell Physiol 171:252-258.
28. Groopman JE (1980). The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92:857-858.
29. Hirschi KK and D'Amore PA (1997). Control of angiogenesis by the pericyte: Molecular mechanisms and significance. EXS 79:419-428.
30. Ingber D (1991). Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J Cell Biochem 47:236-241.
31. Ishikawa F, Miyazono K, Hellman U, Drexler H, Werntedt C, Hagiwara K, Usuki K, Takaku F, Risau W, and Heldin CH (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562.
32. Iversen PO, Nicolaysen G, and Benestad HB (1992). Blood flow to bone marrow during development of anemia or polycythemia in the rat. Blood 79:594-601.
33. Iversen PO, Nicolaysen G, and Benestad HB (1993). The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow. Exp Hematol 21:231-235.
34. Jackson JR, Seed MP, Kircher CH, Willoughby DA, and Winkler JD (1997). The codependence of angiogenesis and chronic inflammation. FASEB J 11:457-465.
35. Jacobson RJ, Salo A, and Fialkow PJ (1978). Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189-194.
36. Kubota Y, Kleinman HK, Martin GR, and Lawley TJ (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589-1598.
37. Lichman MA (1984). The relationship of stromal cells in marrow. In: Wright DG and Greenberger JS, editors. Longterm bone marrow culture. New York, 3-29.
38. Ma J, Fei ZL, Klein-Szanto A, and Gallo JM (1998). Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. Clin Exp Metastasis 16:559-568.
39. Montesano R, Mouron P, and Orci L (1985). Vascular outgrowths from tissue explants embedded in fibrin or collagen gels: A simple in vitro model of angiogenesis. Cell Biol Int Rep 9:869-875.
40. Montesano R and Orci L (1987). Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J Cell Physiol 130:284-291.
41. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, and Ziehe M (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270: H411-H415.
42. Orlidge A and D'Amore PA (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455-1462.
43. Palmer RM, Ferrige AG, and Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
44. Paulsson M (1992). Basement membrane proteins: Structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27:93-127.
45. Perez-Atayde A, Sallan SE, Tedraw U, Connors S, Allred E, and Folkman J (1997). Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150:815-821.
46. Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, Moore MAS, Asch AS (1994). Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion. Blood 84:10-19.
47. Reilly JT, Nash JRG, Mackie MJ, and McVerry BA (1985). Endothelial cell proliferation in myelofibrosis. Br J Haematol 60:625-630.
48. Sato Y and Rifkin DB (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
49. Sato Y, Okamura K, Morimoto A, Hamanaka R, Hamagushi K, Shimada T, Ono M, Kohno K, Sakata T, and Kuwano M (1993). Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp Cell Res 204: 223-229.
50. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
51. Sensebe L, Deschaseaux M, Li J, Herve P, and Charbord P (1997a). The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment. Stem Cells 15:133-143.
52. Sensebe L, Li J, Lilly M, Crittenden C, Herve P, Charbord P, and Singer JW (1995). Nontransformed colony-derived stromal cell lines from normal human marrows. I. Growth requirement and myelopoiesis supportive ability. Exp Hematol 23: 507-513.
53. Sensebe L, Mortensen BT, Fixe P, Herve P, and Charbord P (1997b). Cytokines active on granulomonopoiesis: Release and consumption by human marrow myoid stromal cells. Br J Haematol 98:274-282.
54. Shi Q, Rafii S, Wu MHD, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, and Hammond WP (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367.
55. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
56. Van Dyke D, Anger HO, Parker H, McRae J, and Dobson EL, Yano Y, Naets, JP, Linfoot J (1970). Markedly increased bone blood flow in myelofibrosis. J Nucl Med 12:506-512.
57. Wilson JG and Tavassoli M (1994). Microenvironmental factors involved in the establishment of erythropoiesis in bone marrow. Ann NY Acad Sci 718:271-284.